Paid Clinical Trials in New Jersey
Here are the 6 most popular medical studies in Paid Studies New Jersey
Tyrosine Kinase Inhibitor
Cabozantinib for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 2
New York, New York
This trial will help us understand if cabozantinib can help patients with gene RET, ROS1, or NTRK fusion or increased MET or AXL activity by inhibiting these genes that lead to lung cancer cell growth.
Popular filter options for Paid Studies New Jersey trials
Phase 3 Clinical Trials
View 93 phase 3 medical studies.
Alkylating agents
Combination Chemotherapy for Ewing's Sarcoma
Recruiting4 awardsPhase 3
Hackensack, New Jersey
This trial is studying different combination chemotherapy regimens to see how well they work when given with or without peripheral stem cell transplantation, radiation therapy, and/or surgery in treating patients with Ewing's sarcoma.
Platinum-based Chemotherapy
Chemo-Radiation for Early-Stage Cervical Cancer
Recruiting2 awardsPhase 3
Newark, New Jersey
This trial is studying how well giving chemotherapy and pelvic radiation therapy together with or without additional chemotherapy works in treating patients with high-risk early-stage cervical cancer.
Janus Kinase (JAK) Inhibitor
Tofacitinib for Juvenile Arthritis
Recruiting1 awardPhase 2 & 3
Hackensack, New Jersey
This trial will evaluate the long-term safety and tolerability of tofacitinib in patients with juvenile idiopathic arthritis (JIA) who have previously participated in tofacitinib JIA studies.
Clinical Trials With No Placebo
View 93 medical studies that do not have a placebo group.
Alkylating agents
Surgery + Chemotherapy + IMRT for Mesothelioma
Recruiting1 awardPhase 2
New York, New York
This trial is testing a new, safer radiation therapy for people with a certain type of lung cancer. The old radiation therapy had lots of side effects, but the new one specifically targets the cancer and reduces the risk of damaging healthy tissue.
Alkylating agents
Combination Chemotherapy for Ewing's Sarcoma
Recruiting4 awardsPhase 3
Hackensack, New Jersey
This trial is studying different combination chemotherapy regimens to see how well they work when given with or without peripheral stem cell transplantation, radiation therapy, and/or surgery in treating patients with Ewing's sarcoma.
Platinum-based Chemotherapy
Chemo-Radiation for Early-Stage Cervical Cancer
Recruiting2 awardsPhase 3
Newark, New Jersey
This trial is studying how well giving chemotherapy and pelvic radiation therapy together with or without additional chemotherapy works in treating patients with high-risk early-stage cervical cancer.
View More Paid Studies New Jersey Trials
See another 77 medical studies focused on Paid Studies New Jersey.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.